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Abstract : Study Objective : the incidence of postoperative nausea and vomiting (PONV) following single-injec-
tion intraarticular anesthesia was compared to that following continuous epidural anesthesia.  Design : Prospec-
tive, double-blind, randomized study. Setting : University-affiliated teaching hospital. Patients : Forty-eight 
patients finally participated in this study, and each group contained twenty-four patients. Interventions : Pa-
tients scheduled to undergo lower limb surgery under general anesthesia were randomly allocated into two 
groups, to receive either single-injection intraarticular or continuous epidural anesthesia for postoperative 
analgesia.  Measurements : The incidence and severity of PONV, complete response rates (i.e., no vomiting or 
rescue antiemetic use), and pain scores were recorded 2, 24, and 48 h postoperatively. Main results : No signifi-
cant differences between groups were observed in the incidence and severity of PONV, rescue antiemetic use, or 
complete response rate at any of the time points, but only the use of rescue analgesics was significantly less in 
continuous epidural anesthesia group during the 2-24h postoperative period (P=0.04). Conclusion : While the use 
of single-injection intraarticular anesthesia following lower limb surgery did not prevent PONV more than con-
tinuous epidural anesthesia in this study, the intraarticular technique still provides greater simplicity, safety, 
and cost-effectiveness. J. Med. Invest. 66 : 303-307, August, 2019
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INTRODUCTION
 
Postoperative nausea and vomiting (PONV) is a distressing 
complication that can adversely affect patient recovery ; it fre-
quently delays patient discharge from the post-anesthesia care 
unit and is the leading cause of unexpected hospital admission 
following planned ambulatory surgery (1). PONV is considered 
by many patients to be more distressing than postoperative pain 
(2). The general incidence of PONV is approximately 50% and 
in a subset of high-risk patients, PONV rates can be as high as 
70% (3, 4, 5, 6). The four main risk factors of PONV include the 
female sex, a history of PONV or motion sickness, being a non-
smoker, and the use of postoperative opioids (7).
Immediate postoperative pain following lower limb surgery 
can be severe and sometimes difficult to manage. Postoperative 
pain relief can be achieved using a variety of techniques, such 
as intravenous analgesia, epidural analgesia, peripheral nerve 
blocks, and local anesthetic infiltration. Effective treatment of 
postoperative pain and controlling side effects are important 
to enable early rehabilitation and hospital discharge following 
lower limb surgery (8). Continuous epidural analgesia has been 
shown to provide better pain relief than systemic opioid admin-
istration, but is associated with significant side effects, including 
nausea, urinary retention, hypotension, and delayed mobilization. 
Furthermore, use of epidural analgesia may delay initiation of 
anticoagulant thromboprophylaxis due to the potential risk of 
epidural hematoma (8, 9). Local infiltration of analgesics com-
bined with a single-injection or continuous infusion of local an-
esthetics at the surgical site has been reported as an alternative 
method for achieving effective postoperative pain relief (10, 11). 
Additionally, various combinations of drugs and local infiltration 
techniques (i.e., drug mixture, and the use of a wound catheter) 
have been evaluated (11,12,13). Among them, use of the intraar-
ticular analgesic method has been shown to potentially reduce 
the occurrence of side effects while maintaining adequate pain 
relief and maximum muscle control. However, these studies 
have provided conflicting results owing to their differing study 
designs (14, 15, 16,17,18). 
Since intraarticular anesthesia is administered by the sur-
geon intraoperatively and acts locally, we predicted that the 
rate of complications following intraarticular anesthesia may be 
less than that of other methods. Therefore, the purpose of this 
study was to compare the incidence of PONV following the use 
of intraarticular local anesthesia to that following continuous 
epidural anesthesia, after lower limb surgery. 
PATIENTS AND METHODS
The current prospective study was approved by the Human 
Research Ethics Committee of Tokushima University Hospital 
and registered in the clinical trials database (UMIN000019978). 
Informed consent was obtained from all patients, and the study 
was conducted in accordance with the principles outlined in the 
Declaration of Helsinki. 
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Patients aged 30–85 years, with an American Society of Anes-
thesiologists (ASA) physical status of Ⅰ–Ⅲ, that were scheduled 
to undergo lower limb surgery (total knee arthroplasty, total hip 
arthroplasty, or rotational acetabular osteotomy) under general 
anesthesia were enrolled in this prospective study between No-
vember 2015 and July 2016. The patients’ information, including 
their sex, history of PONV and/or motion sickness, and smoking 
status, was recorded. The exclusion criteria were as follows : an 
ASA physical status of Ⅳ, abnormal liver and/or renal function, 
or use of antiemetics.
No preanesthetic medication was administered. All patients 
were monitored using electrocardiography, noninvasive arterial 
blood pressure, pulse oximetry, and capnography. General anes-
thesia was induced with remifentanil, propofol, and rocuronium 
to facilitate endotracheal intubation, and was maintained using 
volatile anesthetics (sevoflurane 1–2% and desflurane 4–6%) 
in oxygen, with a mixture of remifentanil 0.1–0.5 μg/kg/min 
and fentanyl 0–100 μg. Incremental doses of rocuronium were 
administered, as necessary, for neuromuscular blockade, the 
effects of which were reversed using sugammadex 2 mg/kg upon 
surgery completion. 
Prior to undergoing surgery, the patients were randomly al-
located into one of two groups according to which postoperative 
analgesia method they were to receive : single-injection intraar-
ticular anesthesia or continuous epidural anesthesia. The pa-
tients that received intraarticular anesthesia (i.e., Group I) were 
administered ropivacaine 200 mg and dexamethasone 6.6 mg, 
mixed with sterile normal saline to comprise a combined volume 
of 40 mL. Patients that were to receive continuous epidural an-
esthesia (i.e., Group E) underwent epidural catheter placement 
at either L2–3 or L3–4, followed by epidural administration of 
fentanyl 0.1 μg/kg/ml, total 10ug/kg and local anesthetic (0.125% 
levobupivacaine, 2–4 ml/h) ; this was maintained for > 48 h. A 
rescue analgesic (dicrofenac sodium 25mg sup. or loxoprofen so-
dium 60mg p.o.) was administered upon patient request for both 
groups. Intravenous metoclopramide (10 mg) was administered 
as a rescue antiemetic when necessary.
The incidence and severity of PONV, complete response rate, 
and the patients’ pain scores (using a visual analog scale [VAS]) 
were recorded 2, 24, and 48 h after surgery by blinded observers. 
The severity of nausea was recorded using the following scale : 0, 
absence of nausea ; 1, mild nausea ; 2, moderate nausea ; or 3, 
severe nausea. The complete response rate was defined as no oc-
currence of vomiting and no rescue antiemetic use. The patients’ 
analgesic demands were also recorded.
Statistical analysis
Statistical analyses were performed using SPSS software, 
version 22 (SPSS Inc., Chicago, IL, USA). The data are ex-
pressed as the mean ± standard deviation (SD). P values < 0.05 
were considered statistically significant without any adjustment 
for multiplicity of testing.
 The t-test, χ2 test, and Fisher’s exact test were used to ana-
lyze the patient demographics, cumulative incidence of vomiting 
at each time point, rescue antiemetic use, complete response 
rate, and VAS pain scores. The Mann-Whitney U test was used 
to analyze the nausea severity scores.
RESULTS
Of 53 patients considered eligible for the study, 3 refused and 
50 agreed to participate. One patient was excluded due to the op-
eration being called off and one patient was excluded to occlusion 
of the epidural catheter (Figure 1). Twenty-four patients received 
intraarticular anesthesia (Group I), and 24 received continuous 
epidural anesthesia (Group E). The demographic data were 
similar for both groups with respect to age, sex, weight, ASA 
physical status, smoking status, and history of motion sickness 
and PONV. Similarly, there were no differences in the durations 
of anesthesia or surgery, or the amount of blood loss (Table 1).
There were no significant differences observed in the inci-
dence of PONV, nausea severity scores, rescue antiemetic use, or 
complete response rate between the two groups at any time point 
Figure 1.　CONSORT flow chart showing the selection process for patients.
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(Table 2). The VAS pain scores were also not significantly differ-
ent between the groups ; however, the use of rescue analgesics 
was significantly less in Group E during the 2–24-h postopera-
tive period (Table 3).
 
DISCUSSION
In this study, we compared the intraarticular injection tech-
nique with continuous epidural infusion for postoperative an-
algesia, and found no significant differences in the incidence or 
severity of PONV, complete response rate, or the use of rescue 
antiemetics between the two methods. The benefits of intraartic-
ular analgesia have been evaluated previously, primarily with 
patients having underwent knee surgery ; a systematic review of 
previous studies demonstrated evidence of reduced pain during 
the immediate and early postoperative periods following intraar-
ticular local anesthesia after knee surgery (15, 18). However, 
some studies have demonstrated the effectiveness of intraarticu-
lar analgesia following hip surgery (11,12). In the current study, 
we included patients undergoing knee or hip surgery, and found 
that intraarticular analgesia was effective for pain management 
following both types of surgery.
We noted that there was a significant difference between the 
two study groups regarding the use of rescue analgesics during 
the 2–24-h postoperative period. Since single-injection intraar-
ticular analgesia only remains effective short period (19,20), it 
is reasonable that patients in Group I required rescue analgesia 
more often than those in Group E. However surgical site, knee 
or hip, and the invasiveness, i.e. total knee arthroplasty > total 
hip arthroplasty, may influence on the results for the use of 
rescue analgesics. Although, there was no statistically signifi-
cant difference, Group I tended to have more knee surgery than 
Group E. Use of continuous wound catheters may reduce the 
need for rescue analgesics ; however, we chose not to utilize them 
in the present study owing to concerns regarding the possible 
increased risks of infection and delayed wound healing (8, 21). 
Previous studies investigating the efficacy of local infiltration 
analgesia after knee surgery did not demonstrate an increased 
frequency of infections, but the follow-up periods in these studies 
were very limited (10, 22, 23). Therefore, it should be further in-
vestigated whether combining intraarticular injections and con-
tinuous infusion of local anesthesia to surgical sites can provide 
more effective pain control than traditional methods. 
Ropivacaine is a relatively new, long-acting, aminoamide local 
anesthetic agent (24) that is chemically homologous to bupiva-
caine and mepivacaine (25). It demonstrates similar clinical ef-
ficacy to racemic bupivacaine, but is less cardio- and neurotoxic, 
and induces less vasodilation. The peak plasma concentration 





(n = 24) P-value
0–2-h Postoperative period
　PONV 5 6 P = 0.36
　Vomiting (no. of episodes) 4 8 P = 0.37
　Nausea scores (0/1/2/3) 19/1/0/4 18/0/1/5 P = 0.71
　Rescue antiemetic use 4 2 P = 0.33
　Complete response (%) 20 (83%) 19 (79%) P = 0.5
2–24-h Postoperative period
　PONV 2 6 P = 0.12
　Vomiting (no. of episodes) 0 4 P = 0.10
　Nausea scores (0/1/2/3) 22/0/1/1 18/1/3/2 P = 0.14
　Rescue antiemetic use 1 2 P = 0.5
　Complete response (%) 23 (96%) 21 (88%) P = 0.3
24–48-h Postoperative period
　PONV 1 4 P = 0.17
　Vomiting (no. of episodes) 0 2 P = 0.16
　Nausea scores (0/1/2/3) 23/0/1/0 20/2/0/2 P = 0.16
　Rescue antiemetic use 1 1 P = 0.76
　Complete response (%) 23 (96%) 22 (92%) P = 0.5
Data are presented as the number of patients (percentile), unless 
otherwise stated. 
Group I, intraarticular anesthesia group ; Group E, continuous epi-
dural anesthesia group ; PONV, postoperative nausea and vomiting.
Nausea scores : 0, absence of nausea ; 1, mild nausea ; 2, moderate 
nausea ; or 3, severe nausea.






　Age (years) 67.1 ± 9.6 60.5 ± 13.9
　Sex (Male : Female) 8:16 7:17
　Height (cm) 154.0 ± 7.1 157.6 ± 7.2
　Weight (kg) 58.6 ± 11.0 60.7 ± 13.3
　ASA physical status (I/II/III) 3/19/2 7/16/1
Risk factors
　Smoker 1 1
　History of motion sickness 2 3
　History of PONV 3 4
Surgery-/anesthesia-related parameters
　Duration of anesthesia (min) 248.5 ± 57.8 256.3 ± 49.8
　Duration of surgery (min) 180.1 ± 59.4 189 ± 66.0
　Blood loss (ml) 429.5 ± 393.6 487.0 ± 442.8
　Type of surgery (Hip : Knee) 18 : 6 22 : 2
　　Total hip arthroplasty 17 20
　　Rotational acetabular osteotomy 1 2
　　Total knee arthroplasty 6 2
Data are presented as the mean ± standard deviation, or number 
(n).
Group I, intraarticular anesthesia group ; Group E, continuous 
epidural anesthesia group ; ASA, American Society of Anesthesiol-
ogists ; PONV, postoperative nausea and vomiting.




(n = 24) P-value
0–2-h Postoperative period
　Rescue analgesic use (%) 9 (38%) 10 (42%) P = 0.5
　VAS pain score 4.4 ±  3.5 4.5 ± 4.1 P = 0.91
2–24-h Postoperative period
　Rescue analgesic use (%) 13 (54%) 6 (25%) P = 0.04#
　VAS pain score 2.3 ± 2.0 2.3 ± 2.7 P = 0.9
24–48-h Postoperative period
　Rescue analgesic use (%) 9 (38%) 7 (29%) P = 0.38
　VAS pain score 1.4 ± 1.9 2.5 ± 2.6 P = 0.10
Data are presented as the number of patients (percentile) or the 
mean ± standard deviation. 
Group I, intraarticular anesthesia group ; Group E, continuous epi-
dural anesthesia group ; VAS, visual analog scale (0, no pain ; to 10, 
the worst pain imaginable).
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shown to be proportional to the dose administered, and remains 
below the recognized toxicity level after administration of 200 
mg (19,20). Therefore, we chose to administer 200 mg of ropiva-
caine for intraarticular anesthesia in our study.
A few previous studies have quantified the incidence of PONV 
after intraarticular analgesia ; Lykoudi et al. (26) found no signif-
icant difference between ropivacaine and a placebo, and Rauto-
ma et al. (27) reported that the incidence PONV for patients that 
received ropivacaine was lower than that of those who received 
a placebo. However, intraarticular ropivacaine and morphine 
administration has been associated with a higher incidence of 
PONV (16), but these study participants were only observed for a 
short period (24-h). In the present study, we did not observe any 
significant reduction in PONV during the 48-h postoperative 
period. 
This study had several limitations. First, we did not define the 
dose of fentanyl for continuous epidural anesthesia, which may 
have affected the study’s results. Second, dexamethasone was 
used as an adjuvant drug in the intraarticular analgesia group. 
Dexamethasone is a potent and highly selective glucocorticoid 
with minimal mineralocorticoid effects. It inhibits nociceptive 
impulse transmission along myelinated C-fibers, and when 
combined with local anesthetics, it increases the duration of re-
gional blocks (28, 29). Intraarticular ropivacaine has only been 
shown to be effective when it is administered with other drugs, 
not when used alone (15) ; therefore, dexamethasone was used 
in this study to increase analgesic efficacy. The corticosteroid 
dexamethasone effectively prevents nausea and vomiting in 
postoperative patients. However, in this study, it may have acted 
locally via steroid receptors, it could not have acted systemical-
ly ; therefore, it could not prevent PONV. Finally, antiemetic use 
was restricted to only metoclopramide in this study ; however, 
use of other antiemetics may have reduced PONV.
In conclusion, the use of single-injection intraarticular anes-
thesia following lower limb surgery did not prevent PONV more 
than continuous epidural anesthesia in this study. However, the 
greater simplicity, safety, and cost effectiveness of the intraar-
ticular technique is apparent. Therefore, further studies are 
needed to further decrease the incidence of PONV.
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